BAX vs MCK vs RVP Stock Comparison

Baxter International, Mckesson and Retractable Technologies Prices as of Oct 28, 2026 Peers: Industry group
BAX Baxter International Inc
$25.49 +8.5% 1M +11.5% 1Y
Market cap
$13.18B
P/E
–
Revenue (TTM)
$5.55B
Div. yield
0.16%
Medical Supplies Healthcare
1 win
MCK Mckesson Corp
$960.80 +12.2% 1M +19.4% 1Y
Market cap
$112.02B
P/E
24.8x
Revenue (TTM)
$410.98B
Div. yield
0.35%
Drug Distribution Healthcare
10 wins

Head to Head

11 decided of 12

Mckesson leads on 10 of the 12 questions below (Mckesson 10, Baxter International 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBAXMCKRVPLeader
Larger companyMarket capitalisation $13.18B $112.02B $17.36M MCK
Cheaper on earningsLower P/E, profitable companies only -12.4x 24.8x -4.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 12.9x 20.4x — BAX
Faster revenue growthRevenue growth, trailing twelve months -49.1% +8.8% -11.2% MCK
More profitableNet margin, trailing twelve months -19.2% 1.1% -10.6% MCK
Better return on capitalReturn on invested capital 3.4% 107.9% -31.4% MCK
Less leveragedLower net debt / EBITDA 4.8x 0.6x 2.6x MCK
Higher dividend yieldTrailing dividend yield 0.16% 0.35% — MCK
Better 1-year returnPrice return, last 12 months +11.5% +19.4% -35.8% MCK
Better 5-year returnAnnualised price return, 5 years -20.3%/yr +35.8%/yr -42.8%/yr MCK
Less volatileAnnualised volatility, 1 year 44.4% 30.7% 40.2% MCK
Higher overall scoreMean of the five percentile scores vs peers 45/100 58/100 52/100 MCK

Percentile Scorecard

BAXMCKRVP

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBAXMCKRVP
Valuation 83 #39 of 227 50 #13 of 25 72 #65 of 227
Growth 21 #174 of 219 65 #9 of 24 34 #146 of 219
Profitability 73 #56 of 205 65 #9 of 24 40 #124 of 205
Financial Health 19 #192 of 237 48 #14 of 26 65 #84 of 237
Shareholder Returns 29 #96 of 135 60 #7 of 16 –
Overall 45 58 52
  • BAX ranked among 247 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • RVP ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBAXMCKRVPSPY
1 month +8.5%+12.2%-15.9% +0.9%
3 months +2.9%+8.1%-13.4% +5.9%
6 months +50.8%+16.8%-6.6% +8.5%
Year to date +33.4%+17.1%-24.9% +13.3%
1 year +11.5%+19.4%-35.8% +12.4%
3 years -20.7%+114.4%-45.3% +88.1%
3 years, per year -7.5%+29.0%-18.2% +23.5%
5 years -67.7%+362.2%-93.9% +68.2%
5 years, per year -20.3%+35.8%-42.8% +11.0%
10 years -46.0%+674.2%-76.8% +263.4%
10 years, per year -6.0%+22.7%-13.6% +13.8%

Risk

MeasureBAXMCKRVPSPY
Volatility, 1Y 44.4%30.7%40.2% 12.7%
Downside volatility, 1Y 48.2%27.4%44.8% 12.7%
Beta vs S&P 500, 1Y 1.16-0.270.16 1.00
Return / volatility, 1Y 0.260.63-0.89 0.98
Max drawdown, 5Y -82.3%-27.2%-94.0% -25.4%
From 52-week high -10.1%-6.7%-35.8% -0.9%
52-week high $28.35$1,030.18$0.90 $779.14
52-week low $15.80$725.17$0.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBAXMCKRVP
P/E now vs peer median -12.4xmedian 28.8x 24.8xmedian 23.9x -4.8xmedian 28.8x
P/S now vs peer median 2.4xmedian 3.0x 0.3xmedian 0.3x 0.5xmedian 3.0x
EV/EBITDA now vs peer median 13.5xmedian 17.4x 16.1xmedian 12.7x 1.5xmedian 17.4x
P/FCF now vs peer median 15.7xmedian 25.7x 17.5xmedian 15.4x -3.4xmedian 25.7x
P/B now vs peer median 2.1xmedian 2.4x -26.4xmedian 2.5x 0.2xmedian 2.4x
PEG now vs peer median -0.43median 1.03 2.08median 1.34 0.22median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBAXMCKRVP
Revenue $5.55B $410.98B $33.90M
Gross profit $3.78B $14.96B -$491.51K
Operating income $532.00M $6.50B -$22.68M
Net income -$1.06B $5.30B -$3.37M
Free cash flow $839.00M $6.42B -$5.11M
R&D $542.00M – $682.03K
EPS (diluted) $-2.05 $38.52 $-0.12
Cash & equivalents $2.15B $5.16B $2.64M
Total debt $9.46B $9.73B $3.40M
Shares (diluted) 518.00M 119.20M 29.94M
Enterprise value $5.28B $98.48B -$129.04M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBAXMCKRVP
P/E -12.4x 24.8x -4.8x
P/FCF 15.7x 17.5x -3.4x
P/Operating cash flow 9.8x 16.3x -3.5x
P/S 2.4x 0.3x 0.5x
P/B 2.1x -26.4x 0.2x
P/Tangible book 6.2x -13.6x 0.2x
EV/EBITDA 13.5x 16.1x 1.5x
EV/EBIT 38.5x 18.0x 1.0x
EV/Revenue 3.7x 0.3x -0.6x
EV/FCF 24.4x 18.2x 4.3x
EV/Operating cash flow 15.3x 17.0x 4.4x
PEG (3Y EPS CAGR) -0.43 2.08 0.22

Growth

14 metrics
MetricBAXMCKRVP
Revenue growth (1Y) -49.1% 8.8% -11.2%
Revenue CAGR (3Y) -23.5% 13.1% -14.7%
Gross profit growth (1Y) -1.8% 11.2% 81.2%
Gross profit CAGR (3Y) -5.2% 6.6% -26.8%
Operating income growth (1Y) -50.8% 46.6% -2.3%
Operating income CAGR (3Y) 29.5% 13.5% -11.7%
Net income growth (1Y) -604.0% 58.1% 61.4%
Net income CAGR (3Y) 28.0% 10.7% -23.9%
EPS growth (1Y) -580.5% 52.8% 59.8%
EPS CAGR (3Y) 28.6% 12.0% -21.9%
Operating cash flow growth (1Y) 56.3% 4.7% 58.8%
Operating cash flow CAGR (3Y) -4.8% 10.7% -16.8%
Free cash flow growth (1Y) 153.5% 6.8% 62.3%
Free cash flow CAGR (3Y) -9.5% 11.3% 20.0%

Profitability

14 metrics
MetricBAXMCKRVP
Gross margin 68.1% 3.6% -1.4%
EBITDA margin 27.3% 1.8% -43.9%
Operating margin 9.6% 1.6% -66.9%
Pretax margin 5.1% 1.6% -9.9%
Net margin -19.2% 1.1% -10.6%
FCF margin 15.1% 1.6% -15.1%
Operating cash flow margin 24.2% 1.7% -14.6%
Return on equity -17.4% – -4.7%
Return on assets -5.4% 6.2% -2.4%
Return on invested capital 3.4% 107.9% -31.4%
Return on capital employed 3.3% 43.4% -18.0%
Asset turnover 0.3x 4.8x 0.2x
Cash conversion (OCF / net income) -1.3x 1.3x 1.5x
Stock comp / revenue 2.1% – –

Financial Health

11 metrics
MetricBAXMCKRVP
Debt / assets 47.8% 11.0% 0.5%
Debt / equity 1.5x -2.3x 0.0x
Net debt / EBITDA 4.8x 0.6x 2.6x
Debt / FCF 11.3x 1.5x -0.1x
Liabilities / assets 68.6% 104.8% 48.6%
Equity / assets 31.4% -4.8% 51.4%
Interest coverage – 23.6x -278.8x
Current ratio 1.9x 0.9x 4.9x
Quick ratio 1.1x 0.5x 3.7x
Cash ratio 0.6x 0.1x 3.0x
Altman Z-score 2.13 5.88 0.43

Shareholder Returns

7 metrics
MetricBAXMCKRVP
Dividend yield 0.2% 0.4% –
Net buyback yield -0.2% 5.9% –
Shareholder yield 0.0% 6.3% –
Payout ratio (earnings) -17.3% 7.4% –
Payout ratio (FCF) 21.9% 6.1% –
Dividend growth (1Y) -60.8% 11.3% –
Dividend CAGR (3Y) -32.0% 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBAXMCKRVP
Forward P/E 12.9xFY2026 20.4xFY2026 –
EPS, next fiscal year $1.98FY2026 $47.15FY2026 –
EPS growth, next FY -10.4%FY2026 +20.6%FY2026 –
EPS growth, the year after -3.5% +11.0% –
Revenue, next fiscal year $11.05BFY2026 $444.47BFY2026 –
Revenue growth, next FY -1.7%FY2026 +10.2%FY2026 –
Revenue growth, the year after +11.7% +1.5% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBAXMCKRVP
Held by institutions 100.0% 89.1% 8.8%
Institutions holding 690 2,010 32
Change in shares held, QoQ +5.2% -0.7% +5.9%
Institutions buying 359 882 10
Institutions selling 193 791 4
Buyers to sellers 1.86 1.12 2.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BAXMCKRVP
BAX 1.00 0.16 0.06
MCK 0.16 1.00 -0.16
RVP 0.06 -0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BAX, MCK and RVP?

Mckesson (MCK) is the largest by market capitalisation: Baxter International (BAX) $13.18B, Mckesson (MCK) $112.02B, Retractable Technologies (RVP) $17.36M.

Which company is growing faster?

Mckesson (MCK) grew revenue fastest over the trailing twelve months: Baxter International (BAX) -49.1%, Mckesson (MCK) +8.8%, Retractable Technologies (RVP) -11.2%.

Which company is more profitable?

Mckesson (MCK) has the highest net margin (Baxter International (BAX) -19.2%, Mckesson (MCK) 1.1%, Retractable Technologies (RVP) -10.6%). On return on invested capital, Mckesson (MCK) leads (Baxter International (BAX) 3.4%, Mckesson (MCK) 107.9%, Retractable Technologies (RVP) -31.4%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Baxter International (BAX) +11.5%, Mckesson (MCK) +19.4%, Retractable Technologies (RVP) -35.8%. Over five years, Mckesson (MCK) compounded fastest (Baxter International (BAX) -20.3%/yr, Mckesson (MCK) +35.8%/yr, Retractable Technologies (RVP) -42.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Mckesson (MCK) has the highest dividend yield: Baxter International (BAX) 0.16%, Mckesson (MCK) 0.35%. Retractable Technologies (RVP) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Baxter International (BAX) 44.4%, Mckesson (MCK) 30.7%, Retractable Technologies (RVP) 40.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BAX, MCK and RVP?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 10. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.